YU182091A - Postupak za proizvodnju oblika čvrste jedinične doze sa kontrolisanim oslobadjanjem - Google Patents

Postupak za proizvodnju oblika čvrste jedinične doze sa kontrolisanim oslobadjanjem

Info

Publication number
YU182091A
YU182091A YU182091A YU182091A YU182091A YU 182091 A YU182091 A YU 182091A YU 182091 A YU182091 A YU 182091A YU 182091 A YU182091 A YU 182091A YU 182091 A YU182091 A YU 182091A
Authority
YU
Yugoslavia
Prior art keywords
production
controlled release
procedure
dose forms
united
Prior art date
Application number
YU182091A
Other languages
English (en)
Inventor
P.J.G. Lundberg
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Publication of YU182091A publication Critical patent/YU182091A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Control Of Vending Devices And Auxiliary Devices For Vending Devices (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Postupak za proizvodnju oralnih jediničnih doziranja sa kontrolisanim oslobadjanjem koje sadrže hidroksipropil-metil-celulozu kod koga se vodena granulacija izvodi u prisustvu jednog ili više rastvorenih sredstava koja sprečavaju obrazovanje gela tokom granulisanja, ali omogućavaju obrazovanje gela kada se daju oralno. Isto tako su uključene i nove jedinične doze pripremljene prema pronalasku.
YU182091A 1990-12-07 1991-11-20 Postupak za proizvodnju oblika čvrste jedinične doze sa kontrolisanim oslobadjanjem YU182091A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003904A SE9003904D0 (sv) 1990-12-07 1990-12-07 Method for the manufacture of a pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
YU182091A true YU182091A (sh) 1994-04-05

Family

ID=20381123

Family Applications (1)

Application Number Title Priority Date Filing Date
YU182091A YU182091A (sh) 1990-12-07 1991-11-20 Postupak za proizvodnju oblika čvrste jedinične doze sa kontrolisanim oslobadjanjem

Country Status (20)

Country Link
US (1) US5419918A (sh)
EP (1) EP0560822B1 (sh)
JP (1) JP3239319B2 (sh)
AT (1) ATE130188T1 (sh)
AU (1) AU659114B2 (sh)
CA (1) CA2097175A1 (sh)
DE (1) DE69114721T2 (sh)
DK (1) DK0560822T3 (sh)
ES (1) ES2079689T3 (sh)
FI (1) FI932552A0 (sh)
GR (1) GR3018685T3 (sh)
HU (1) HUT64212A (sh)
IE (1) IE914229A1 (sh)
IS (1) IS3789A7 (sh)
NO (1) NO932054L (sh)
PL (1) PL168605B1 (sh)
PT (1) PT99721A (sh)
SE (1) SE9003904D0 (sh)
WO (1) WO1992010169A1 (sh)
YU (1) YU182091A (sh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
DK0661045T3 (da) * 1992-09-18 2002-10-28 Yamanouchi Pharma Co Ltd Hydrogelpræparat med forsinket frigivelse
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
JP2000034224A (ja) * 1998-05-11 2000-02-02 Freunt Ind Co Ltd 徐放性錠剤、その添加剤組成物及びそれらの製造方法
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
WO2003011256A1 (en) * 2001-07-30 2003-02-13 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition of a prokinetic agent
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
WO2014170755A2 (en) * 2013-04-16 2014-10-23 Murray And Poole Enterprises Limited Sustained-release formulations of colchicine and methods of using same
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
US4559384A (en) * 1983-12-20 1985-12-17 Toyo Soda Manufacturing Co., Ltd. Process for preventing agglomeration of powders by using triethylenediamine polymers
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
EP0294493A4 (en) * 1986-12-25 1989-07-24 Teysan Pharmaceuticals Co Ltd SLOW DISSOLUTION GRANULE AND COMPOSITE GRANULE WITH PERSISTENT EFFECT PREPARED FROM THE FIRST GRANULE.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
US5024842A (en) * 1988-04-28 1991-06-18 Alza Corporation Annealed coats
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition

Also Published As

Publication number Publication date
ATE130188T1 (de) 1995-12-15
JPH06503310A (ja) 1994-04-14
CA2097175A1 (en) 1992-06-08
IE914229A1 (en) 1992-06-17
PT99721A (pt) 1993-04-30
JP3239319B2 (ja) 2001-12-17
PL299376A1 (en) 1994-03-07
AU8930991A (en) 1992-07-08
EP0560822A1 (en) 1993-09-22
HUT64212A (en) 1993-12-28
DK0560822T3 (da) 1996-03-11
WO1992010169A1 (en) 1992-06-25
SE9003904D0 (sv) 1990-12-07
FI932552A (fi) 1993-06-04
DE69114721T2 (de) 1996-04-18
PL168605B1 (pl) 1996-03-29
IS3789A7 (is) 1992-06-08
US5419918A (en) 1995-05-30
EP0560822B1 (en) 1995-11-15
NO932054D0 (no) 1993-06-04
NO932054L (no) 1993-06-04
ES2079689T3 (es) 1996-01-16
DE69114721D1 (de) 1995-12-21
AU659114B2 (en) 1995-05-11
FI932552A0 (fi) 1993-06-04
HU9301672D0 (en) 1993-09-28
GR3018685T3 (en) 1996-04-30

Similar Documents

Publication Publication Date Title
YU182091A (sh) Postupak za proizvodnju oblika čvrste jedinične doze sa kontrolisanim oslobadjanjem
JPS5225013A (en) Insulin pharmaceutical for nasal administration
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
EE05287B1 (et) Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
AR011134A1 (es) Derivados de imidazo piridina substituidos para la inhibicion de la secrecion de acido gastrico; una sal del mismo, procedimiento para su preparacion, formulacion farmaceutica que los contiene y el uso de dicho compuesto para la manufactura de un medicamento
MX9203444A (es) Medicamentos.
ME00181B (me) Farmaceutske formulacije inhibitora renin-angiotenzin sistema (ras) i njihova primjena
IS2216B (is) Meðferðaráform við inngjöf á H+,K+ -ATPasa-hemla
SE9003903D0 (sv) New pharmaceutical formulations
GR1003658B (el) Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου
ES382842A1 (es) Procedimiento para la preparacion de piperazinilalcohilami-no - uracilos, uracileteres y uraciltioeteres aril-sustitui-dos.
SE8901003L (sv) Snabbloesliga preparat
JPS51139617A (en) A process for preparing a remedy for intestinal infectious diseases
IS1664B (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandiog kvalastillandi áhrif
AR012723A1 (es) Derivados triptolidos utiles en el tratamiento de enfermedades autoinmunes y usos en la fabricacion de medicamentos
CS734389A3 (en) 4-fluoro-2-//(4-methoxy-2-pyridyl)methyl/sulfinyl/ -1h - benzimidazole, process for its production and a pharmaceutical comprising said compound as an active component
JPS52108028A (en) Remedies for dysacousis
DK165168C (da) Fremgangsmaade til fremstilling af et basesalt af piroxicam aflejret paa en farmaceutisk acceptabel baerer
AR020142A1 (es) Un compuesto derivado de arginina, una composicion farmaceutica que los comprende y el uso de los mismos para la manufactura de un medicamento paraantagonizar un receptor para c3a
JPS54126722A (en) Slow release antibiotic tablet
ES8504160A1 (es) Procedimiento para la preparacion de derivados de propan-2-ol
MX2020013574A (es) Composicion farmaceutica para la administracion oral que comprende un inhibidor de la bomba de protones con absorcion mejorada.
JPS5240483A (en) Process for dialysis of acid
ES2146614T3 (es) Derivados de azepina, produccion de los mismos y su utilizacion como ligandos del receptor sigma.
AR022475A1 (es) Metodo para la prevencion o reduccion de eventos cardiovasculares asociados con intervencion coronaria.